Successful Combination Immunotherapy for the Generation In Vivo of Antitumor Activity With Anti-CD3, Interleukin 2, and Tumor Necrosis Factor α

Stephen C. Yang, Kim D. Fry, Elizabeth A. Grimm, Jack A. Roth

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Successful Combination Immunotherapy for the Generation In Vivo of Antitumor Activity With Anti-CD3, Interleukin 2, and Tumor Necrosis Factor α'. Together they form a unique fingerprint.

Medicine & Life Sciences